Aptorum Group Limited (APM)
NASDAQ: APM · Real-Time Price · USD
0.759
-0.015 (-1.99%)
Jun 29, 2026, 8:20 AM EDT - Market open
Aptorum Group Employees
Aptorum Group had 1 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
1
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,363,270
Market Cap
6.18M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| BioAtla | 41 |
| NextCure | 40 |
| Cardio Diagnostics Holdings | 17 |
| Soligenix | 14 |
| NuCana | 12 |
| Purple Biotech | 10 |
| Can-Fite BioPharma | 5 |
| Acurx Pharmaceuticals | 4 |
APM News
- 7 days ago - Aptorum Group announces collaboration between DiamiR, AlzLabs - TheFly
- 7 days ago - Aptorum Group Announces Collaboration between DiamiR Biosciences and AlzLabs Precision Diagnostics for Alzheimer's Disease Biomarkers - GlobeNewsWire
- 10 days ago - Statement in Response to Silver Elephant's News Release Dated June 17, 2026 - Newsfile Corp
- 19 days ago - Aptorum Group shareholders approve merger with DiamiR Biosciences - TheFly
- 19 days ago - Aptorum Group Announces Shareholder Approval of Proposed Merger with DiamiR Biosciences - GlobeNewsWire
- 3 months ago - Aptorum Group, DiamiR announce publication of microRNA biomarker study - TheFly
- 3 months ago - Aptorum Group and DiamiR Biosciences Announce Publication of microRNA Glioblastoma Biomarker Study in Diagnostics in Collaboration with the University of Pennsylvania - GlobeNewsWire
- 4 months ago - Aptorum Group receives noncompliance notification from Nasdaq - TheFly